Science Exchange, a leading provider of life sciences procurement and supplier management SaaS solutions, today announced the acquisition of HappiLabs, a Chicago-based software and services company specializing in scientific procurement support. This strategic acquisition strengthens Science Exchange’s ability to serve biotech and pharmaceutical companies by deepening procurement expertise and expanding access to high-quality purchasing insights.

For over a decade, HappiLabs has helped life sciences organizations at all stages of development optimize lab purchasing, vendor management, and the scientific supply chain. Its flagship Virtual Lab Manager (VLM) offering provides hands-on support with purchasing, budgeting, negotiation, product research, and supplier management—empowering scientists to focus on what they do best: the science.

Now, as part of Science Exchange, HappiLabs’ team of PhD-trained procurement experts will gain access to broader technology, resources, and supplier relationships—further enhancing the support available to the scientific community. The addition of HappiLabs brings deep expertise in sourcing specialized lab consumables, and strengthens Science Exchange’s offering for biotech and small-to-mid-sized (SMB) life science companies.

"At Science Exchange we’re committed to accelerating scientific breakthroughs by simplifying access to the best research solutions," said Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange. "The addition of HappiLabs brings specialized procurement expertise to our platform, strengthening our ability to support scientists and procurement teams with personalized guidance, data-driven insights, and smarter purchasing strategies. Together, we’ll deliver greater efficiency and cost savings across the R&D ecosystem."

HappiLabs will continue operating as part of Science Exchange, with its entire team remaining in place to ensure continuity for current customers. The team’s dedication to service excellence is reflected in their outstanding Net Promoter Score (NPS) of 93—a testament to the trust and satisfaction of the scientists who rely on them every day.

Tom Ruginis, Founder & CEO of HappiLabs, will take on a senior leadership role at Science Exchange, focusing on expanding procurement solutions for biotech companies.

"I believe in the power of virtual lab management to streamline and optimize lab operations. Making scientists’ lives easier by handling the complexities of lab purchasing and the scientific supply chain will result in happier scientists and a healthier society," said Ruginis. "By combining our expertise with Science Exchange’s technology and scale, we can deliver even greater value to biotech and pharma companies—helping them operate more efficiently and freeing their scientists to focus on what matters most: the science."

This acquisition is part of Science Exchange’s broader growth strategy, backed by Waud Capital Partners, to strengthen its procurement and supplier orchestration capabilities—delivering greater value to life sciences organizations through operational efficiency and cost savings.

For more information about Science Exchange and HappiLabs, visit info.scienceexchange.com/happilabs.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250331683019/en/

This strategic acquisition strengthens Science Exchange’s ability to serve biotech and pharmaceutical companies by deepening procurement expertise and expanding access to high-quality purchasing insights.